ticlopidine has been researched along with Hematologic Diseases in 8 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Hematologic Diseases: Disorders of the blood and blood forming tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Several rare, potentially fatal types of hematologic dyscrasia, such as agranulocytosis, aplastic anemia, neutropenia, pancytopenia, thrombocytopenia and thrombotic thrombocytopenic purpura (TTP), have been associated with ticlopidine therapy." | 4.80 | Hematologic dyscrasia associated with ticlopidine therapy: evidence for causality. ( Angelo, CM; Cohen, EA; Lanctôt, KL; Paradiso-Hardy, FL, 2000) |
| "Ticlopidine is an inhibitor of platelet action that has been used in the treatment of a variety of disease states in which platelets play a prominent role." | 2.37 | Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states. ( Saltiel, E; Ward, A, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Podolec, J | 1 |
| Gajos, G | 1 |
| Budziaszek, Ł | 1 |
| Czaniecka, M | 1 |
| Kleczkoska, A | 1 |
| Zmudka', K | 1 |
| Wysowksi, DK | 1 |
| Bacsanyi, J | 1 |
| de Jaureguiberry, JP | 1 |
| Galzin, M | 1 |
| Talard, P | 1 |
| Marlier, S | 1 |
| Durupt, S | 1 |
| Bouchiat, C | 1 |
| Dussarat, GV | 1 |
| Jaubert, D | 1 |
| Steinhubl, SR | 1 |
| Topol, EJ | 1 |
| McCullough, PA | 1 |
| Marks, KR | 1 |
| Paradiso-Hardy, FL | 1 |
| Angelo, CM | 1 |
| Lanctôt, KL | 1 |
| Cohen, EA | 1 |
| Hutchinson, TA | 1 |
| Saltiel, E | 1 |
| Ward, A | 1 |
6 reviews available for ticlopidine and Hematologic Diseases
| Article | Year |
|---|---|
[New approach to interventional cardiology treatment with personalized medicine].
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspi | 2008 |
[Bone marrow aplasia related to ticlopidine].
Topics: Aged; Bone Marrow Diseases; Hematologic Diseases; Humans; Male; Middle Aged; Platelet Aggregation In | 1996 |
Clopidogrel with aspirin is the optimal antiplatelet regimen for intracoronary stenting.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Co | 1999 |
Aspirin and ticlopidine after routine coronary stenting: the gold standard as of 1999.
Topics: Anemia, Aplastic; Angioplasty, Balloon, Coronary; Aspirin; Clinical Trials as Topic; Clopidogrel; Co | 1999 |
Hematologic dyscrasia associated with ticlopidine therapy: evidence for causality.
Topics: Bayes Theorem; Dose-Response Relationship, Drug; Female; Hematologic Diseases; Humans; Male; Neutrop | 2000 |
Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states.
Topics: Blood Platelets; Hematologic Diseases; Humans; Kinetics; Platelet Aggregation; Ticlopidine | 1987 |
2 other studies available for ticlopidine and Hematologic Diseases
| Article | Year |
|---|---|
Blood dycrasias and hematologic reactions in ticlopidine users.
Topics: Hematologic Diseases; Humans; Platelet Aggregation Inhibitors; Ticlopidine | 1996 |
Bayesian assessment of adverse drug reactions.
Topics: Bayes Theorem; Hematologic Diseases; Humans; Risk Factors; Ticlopidine | 2000 |